Leveraging autophagy and pyrimidine metabolism to target pancreatic cancer
Dufresne, S.; Kuna, R. S.; Wong, K.; Komarla, A.; Rock, A.; Rosada-Encarnacion, J.; Shen, C.; Mondal, P.; Parham, L. R.; Layng, F. I.; Peck, K. L.; Fowler, A.; Lowy, A. M.; Engle, D.; Tiriac, H.; Shaw, R.; Cosford, N.; Metallo, C.; Towers, C. G.
10.1101/2025.05.29.656904 bioRxivShow abstract
Autophagy inhibitors are promising compounds to treat pancreatic ductal adenocarcinoma (PDA) but their efficacy in patients is unclear, highlighting a need to understand mechanisms of resistance. We uncovered metabolic adaptations that bypass autophagy inhibition. Utilizing PDA cells with acquired resistance to different autophagy inhibitors, we found that severe autophagy depletion induces metabolic rewiring to sustain TCA intermediates and nucleotides for biosynthesis. Long-term autophagy inhibition results in decreased pyruvate decarboxylation and increased pyruvate anaplerosis, likely regulated by lower pyrimidine pools. Cells adapting to autophagy inhibition increase pyrimidine salvage to replenish these pools instead of synthesizing them de novo. Exploiting this metabolic vulnerability, we found that acquired resistance to autophagy inhibition promotes increased pyrimidine salvage and therefore sensitivity to pyrimidine analogues, including gemcitabine and trifluridine/tipiracil, leading to combinatory effects with autophagy inhibitors and pyrimidine analogs. These studies provide mechanistic insight defining how autophagy inhibition can be leveraged to treat PDA.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- PI5P4Kα Regulates Iron Balance to Promote Metabolic Fitness in Pancreatic Cancer 95%
- Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control 95%
- Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer 95%
Similar papers in this journal
- Paradoxical activation of oncogenic signaling as a cancer treatment strategy 96%
- Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets 95%
- Mitochondrial-encoded complex I impairment induces a targetable dependency on aerobic fermentation in Hürthle cell carcinoma of the thyroid 94%
Similar papers in this journal
- Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions 96%
- GABARAP membrane conjugation sequesters the FLCN-FNIP tumor suppressor complex to activate TFEB and lysosomal biogenesis 95%
- Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis 95%
Similar papers in this journal
- Nutrient availability dictates cancer metabolism-based therapeutic responses of non-oncology drugs 96%
- PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 95%
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.